Results 281 to 290 of about 214,320 (304)

Hereditary angioedema with normal C1-inhibitor activity in women

Lancet, The, 2000
Konrad Bork
exaly  

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Lancet, The, 2017
Marc A Riedl, Dumitru Moldovan, Avner Reshef   +2 more
exaly  

C1-INHIBITOR PROTEIN

InPharma, 1980
openaire   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

C1 Inhibitor Autoantibodies

1996
Alvin E. David, Marco Cicardi
openaire   +1 more source

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Protease inhibitors of human plasma. C1-inhibitor (C1-INH).

Journal of medicine, 1986
L J, Prograis, C M, Brickman, M M, Frank
openaire   +1 more source

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
Courtney D Dinardo, Naval G Daver, Jessica K Altman   +2 more
exaly  

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

Lancet, The, 2006
Roger Chou, Philip Korthuis
exaly  

C1-Esterase-Inhibitor

2017
H. Renz, B. Gierten
openaire   +1 more source